EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:30863 - 5-azaorotic acid
| Formula | C4H3N3O4 |
| Net Charge | 0 |
| Average Mass | 157.085 |
| Monoisotopic Mass | 157.01236 |
| SMILES | O=C(O)c1nc(=O)nc(=O)n1 |
| InChI | InChI=1S/C4H3N3O4/c8-2(9)1-5-3(10)7-4(11)6-1/h(H,8,9)(H2,5,6,7,10,11) |
| InChIKey | RYYCJUAHISIHTL-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Chemical Role: | Bronsted acid A molecular entity capable of donating a hydron to an acceptor (Brønsted base). |
| Applications: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. renoprotective agent Any compound that is able to prevent damage to the kidneys. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| 5-azaorotic acid (CHEBI:30863) has role antineoplastic agent (CHEBI:35610) |
| 5-azaorotic acid (CHEBI:30863) has role renoprotective agent (CHEBI:231911) |
| 5-azaorotic acid (CHEBI:30863) is a 1,3,5-triazines (CHEBI:26588) |
| 5-azaorotic acid (CHEBI:30863) is a monocarboxylic acid (CHEBI:25384) |
| 5-azaorotic acid (CHEBI:30863) is a organic molecular entity (CHEBI:50860) |
| 5-azaorotic acid (CHEBI:30863) is a triazines (CHEBI:38102) |
| IUPAC Name |
|---|
| 4,6-dioxo-1,4,5,6-tetrahydro-1,3,5-triazine-2-carboxylic acid |
| INNs | Source |
|---|---|
| oteracil | WHO MedNet |
| oteracilo | WHO MedNet |
| Synonyms | Source |
|---|---|
| 1,4,5,6-tetrahydro-4,6-dioxo-1,3,5-triazine-2-carboxylic acid | ChemIDplus |
| Allantoxanic acid | ChEMBL |
| oteracil | ChEMBL |
| oxonic acid | ChemIDplus |
| Citations |
|---|